Available evidence suggests that fertility improvements observed during therapy stem largely from weight and insulin changes rather than a drug-specific reproductive effect
3.4 Safety and Tolerability During the total semaglutide dosing phase, 228 AEs were reported in 74% (36/49) of subjects in trial 1, and 151 AEs were reported in 84% (27/32) of subjects in trial 2 (Table 2)
Imminent Price War and Market Expansion Analysts project that generic semaglutide formulations will be priced significantly lower, initially 30-50% less than innovator brands, with potential price reductions reaching 70-75% over time
As body fat decreases during weight loss, breast volume typically reduces as well
Prevention Methods Retatrutide injection site reactions can be minimized with practical steps centered on site rotation, proper technique, and temperature awareness
Direct growth hormone injections flood the system with supraphysiological levels that bypass feedback loops